Abbott Laboratories |
ABT |
🇺🇸 |
New York Stock Exchange |
$231.0bn |
S&P 100 S&P 500 S&P Global 100 |
Abbvie Inc |
ABBV |
🇺🇸 |
New York Stock Exchange |
$354.6bn |
S&P 500 S&P 100 |
Abcam |
ABC |
🇬🇧 |
London Stock Exchange |
£2.8bn |
|
Abiomed Inc. |
ABMD |
🇺🇸 |
NASDAQ |
$17.2bn |
S&P 500 |
Adma Biologics Inc |
ADMA |
🇺🇸 |
NASDAQ |
$3.8bn |
|
Advanced Medical Solutions Group |
AMS |
🇬🇧 |
London Stock Exchange |
£467mn |
|
Aflac Inc. |
AFL |
🇺🇸 |
New York Stock Exchange |
$57.9bn |
S&P 500 |
Alcon Inc. |
ALC |
🇨🇠|
SIX Swiss Exchange |
Fr.40.3bn |
STOXX600 |
Align Technology, Inc. |
ALGN |
🇺🇸 |
NASDAQ |
$14.8bn |
S&P 500 |
Alliance Pharma plc |
APH |
🇬🇧 |
London Stock Exchange |
£328mn |
|
AMGEN Inc. |
AMGN |
🇺🇸 |
NASDAQ |
$160.0bn |
S&P 100 NASDAQ 100 S&P 500 |
Animalcare Group Plc |
ANCR |
🇬🇧 |
London Stock Exchange |
£159mn |
|
Argen X SE |
ARGX |
🇧🇪 |
Euronext Brussels |
€37.6bn |
STOXX600 Euronext 100 |
Arix Bioscience Plc |
ARIX |
🇬🇧 |
London Stock Exchange |
£184mn |
|
Aspira Women's Health Inc |
AWH |
🇺🇸 |
NASDAQ |
$4mn |
|
Astellas Pharma Inc. |
4503 |
🇯🇵 |
Tokyo Stock Exchange |
Â¥2630.3bn |
|
Astrazeneca plc |
AZN |
🇬🇧 |
London Stock Exchange |
£179.7bn |
FTSE 100 FTSE 350 FTSE Eurotop 100 S&P Global 100 CBOE 100 CBOE 350 OMX Stockholm 30 STOXX600 |
Avacta Group Plc |
AVCT |
🇬🇧 |
London Stock Exchange |
£154mn |
|
Basilea Pharmaceutica AG |
BSLN |
🇨🇠|
SIX Swiss Exchange |
Fr.591mn |
|
Bavarian Nordic A/S |
BAVA |
🇩🇰 |
Copenhagen Stock Exchange |
kr.13.6bn |
|
Bayer AG |
BAYN |
🇩🇪 |
Frankfurt Stock Exchange |
€20.9bn |
Euro Stoxx 50 DAX 40 FTSE Eurotop 100 S&P Global 100 TSIC Euro30 STOXX600 |
BB Biotech AG |
BION |
🇨🇠|
SIX Swiss Exchange |
Fr.2.1bn |
STOXX600 |
Becton Dickinson & Co. |
BDX |
🇺🇸 |
New York Stock Exchange |
$65.4bn |
S&P 500 |
Beximco Pharmaceuticals Plc. - GDR - Reg S |
BXP |
🇬🇧 |
London Stock Exchange |
£35mn |
|
Biogen Inc |
BIIB |
🇺🇸 |
NASDAQ |
$20.1bn |
NASDAQ 100 S&P 500 S&P 100 |
Biomarin Pharmaceutical Inc. |
BMRN |
🇺🇸 |
NASDAQ |
$13.1bn |
|
Biomerieux |
BIM |
🇫🇷 |
Euronext Paris |
€13.5bn |
STOXX600 |
Bio-Rad Laboratories Inc. - Class A Shares |
BIO |
🇺🇸 |
New York Stock Exchange |
$6.6bn |
S&P 500 |
Biora Therapeutics Inc |
PROG |
🇺🇸 |
NASDAQ |
$3mn |
|
Biosynex |
ALBIO |
🇫🇷 |
Euronext Paris |
€13mn |
|
Bio-Techne Corp |
TECH |
🇺🇸 |
NASDAQ |
$10.4bn |
S&P 500 |
Bluebird bio Inc |
BLUE |
🇺🇸 |
NASDAQ |
$1.4bn |
|
Boiron |
BOI |
🇫🇷 |
Euronext Paris |
€434mn |
|
Boston Scientific Corp. |
BSX |
🇺🇸 |
New York Stock Exchange |
$155.5bn |
S&P 500 |
Bristol-Myers Squibb Co. |
BMY |
🇺🇸 |
New York Stock Exchange |
$113.2bn |
S&P 100 S&P Global 100 S&P 500 |
Canopy Growth Corporation |
WEED |
🇨🇦 |
Toronto Stock Exchange |
C$347mn |
|
Carbios |
ALCRB |
🇫🇷 |
Euronext Paris |
€102mn |
|
Carl Zeiss Meditec A G |
AFX |
🇩🇪 |
Frankfurt Stock Exchange |
€4.9bn |
STOXX600 |
Catalent Inc. |
CTLT |
🇺🇸 |
New York Stock Exchange |
$11.5bn |
S&P 500 |
Cel AI Plc |
CBX |
🇬🇧 |
London Stock Exchange |
£1mn |
|
Celanese Corp - Ordinary Shares - Series A |
CE |
🇺🇸 |
New York Stock Exchange |
$5.8bn |
S&P 500 |
Cencora Inc. |
COR |
🇺🇸 |
New York Stock Exchange |
$47.2bn |
S&P 500 |
Charles River Laboratories International Inc. |
CRL |
🇺🇸 |
New York Stock Exchange |
$8.3bn |
S&P 500 |
Charlottes Web Holdings Inc |
CWEB |
🇨🇦 |
Toronto Stock Exchange |
C$21mn |
|
Compugen Ltd |
CGEN |
🇮🇱 |
Tel Aviv Stock Exchange |
₪696mn |
|
CompuGroup Medical SE & Co. KgaA |
COP |
🇩🇪 |
Frankfurt Stock Exchange |
€1.2bn |
|
Conformis Inc. |
CFMS |
🇺🇸 |
NASDAQ |
$18mn |
|
ConvaTec Group Plc |
CTEC |
🇬🇧 |
London Stock Exchange |
£4.9bn |
FTSE 350 STOXX600 FTSE 100 |
Creative Medical Technology Holdings Inc |
CELZ |
🇺🇸 |
NASDAQ |
$10mn |
|
CRISPR Therapeutics AG |
CRSP |
🇺🇸 |
NASDAQ |
$4.3bn |
|
CSL Ltd. |
CSL |
🇦🇺 |
Australian Stock Exchange |
AU$125.4bn |
|
CVR Partners LP - Unit |
UAN |
🇺🇸 |
New York Stock Exchange |
$853mn |
|
Dechra Pharmaceuticals plc |
DPH |
🇬🇧 |
London Stock Exchange |
£4.4bn |
FTSE 350 CBOE 250 CBOE 350 STOXX600 FTSE 250 |
Dermapharm Holding SE |
DMP |
🇩🇪 |
Frankfurt Stock Exchange |
€2.1bn |
|
Destiny Pharma Plc |
DEST |
🇬🇧 |
London Stock Exchange |
£3mn |
|
Dexcom Inc |
DXCM |
🇺🇸 |
NASDAQ |
$34.9bn |
S&P 500 |
Diasorin S.p.A. |
DIA |
🇮🇹 |
Italian Stock Exchange |
€2.4bn |
STOXX600 |
Dr. Reddy's Laboratories Ltd. - ADR |
RDY |
🇺🇸 |
New York Stock Exchange |
$11.2bn |
|
DSM-Firmenich AG |
DSFIR |
🇳🇱 |
Euronext Amsterdam |
€27.0bn |
Euronext 100 |
Eco Animal Health Group Plc |
EAH |
🇬🇧 |
London Stock Exchange |
£40mn |
|
Elevation Oncology Inc |
ELEV |
🇺🇸 |
NASDAQ |
$38mn |
|
Ergomed Plc |
ERGO |
🇬🇧 |
London Stock Exchange |
£701mn |
|
Eurofins Scientific S.E. |
ERF |
🇫🇷 |
Euronext Paris |
€9.3bn |
STOXX600 |
Evotec SE |
EVT |
🇩🇪 |
Frankfurt Stock Exchange |
€1.5bn |
STOXX600 |
Exact Sciences Corp. |
EXAS |
🇺🇸 |
NASDAQ |
$9.2bn |
|
Futura Medical |
FUM |
🇬🇧 |
London Stock Exchange |
£43mn |
|
Galapagos NV |
GLPG |
🇳🇱 |
Euronext Amsterdam |
€1.7bn |
STOXX600 BEL 20 AEX 25 |
Genmab |
GMAB |
🇩🇰 |
Copenhagen Stock Exchange |
kr.102.5bn |
STOXX600 |
Genus plc |
GNS |
🇬🇧 |
London Stock Exchange |
£1.2bn |
FTSE 250 FTSE 350 CBOE 250 CBOE 350 |
Gerresheimer AG |
GXI |
🇩🇪 |
Frankfurt Stock Exchange |
€2.9bn |
STOXX600 |
Getinge AB - Class B Shares |
GETI B |
🇸🇪 |
Stockholm Stock Exchange |
kr53.6bn |
STOXX600 |
Gilead Sciences, Inc. |
GILD |
🇺🇸 |
NASDAQ |
$137.1bn |
S&P 100 NASDAQ 100 S&P 500 |
Grifols SA |
GRF |
🇪🇸 |
Barcelona Stock Exchange |
€8.9bn |
IBEX 35 STOXX600 |
GSK Plc |
GSK |
🇬🇧 |
London Stock Exchange |
£60.0bn |
FTSE 100 FTSE 350 FTSE Eurotop 100 S&P Global 100 STOXX600 CBOE 100 CBOE 350 |
GSK Plc - ADR |
GSK |
🇺🇸 |
New York Stock Exchange |
$76.6bn |
|
Hikma Pharmaceuticals Plc |
HIK |
🇬🇧 |
London Stock Exchange |
£5.1bn |
FTSE 350 CBOE 100 CBOE 350 STOXX600 FTSE 250 FTSE 100 |
H. Lundbeck AS |
LUN |
🇩🇰 |
Copenhagen Stock Exchange |
kr.34.4bn |
STOXX600 |
Hologic, Inc. |
HOLX |
🇺🇸 |
NASDAQ |
$14.4bn |
S&P 500 |
hVIVO Plc. |
HVO |
🇬🇧 |
London Stock Exchange |
£121mn |
|
Icon Plc |
ICLR |
🇺🇸 |
NASDAQ |
$16.7bn |
|
Illumina Inc |
ILMN |
🇺🇸 |
NASDAQ |
$15.4bn |
NASDAQ 100 S&P 500 |
Immunovant Inc |
IMVT |
🇺🇸 |
NASDAQ |
$3.5bn |
|
Immunovia AB |
IMMNOV |
🇸🇪 |
Stockholm Stock Exchange |
kr109mn |
|
Incyte Corp. |
INCY |
🇺🇸 |
NASDAQ |
$13.8bn |
S&P 500 |
Indivior Plc |
INDV |
🇬🇧 |
London Stock Exchange |
£909mn |
CBOE 250 CBOE 350 FTSE 250 FTSE 350 |
Integrated Diagnostics Holdings Plc |
IDHC |
🇬🇧 |
London Stock Exchange |
£170mn |
|
Intellia Therapeutics Inc |
NTLA |
🇺🇸 |
NASDAQ |
$1.2bn |
|
Intervacc AB |
IVACC |
🇸🇪 |
Stockholm Stock Exchange |
kr73mn |
|
Ipsen |
IPN |
🇫🇷 |
Euronext Paris |
€9.2bn |
STOXX600 |
Ixico Plc |
IXI |
🇬🇧 |
London Stock Exchange |
£11mn |
|
Johnson & Johnson |
JNJ |
🇺🇸 |
New York Stock Exchange |
$384.4bn |
Dow Jones 30 S&P 100 S&P Global 100 BBC Global 30 S&P 500 |
Kanabo Group Plc |
KNB |
🇬🇧 |
London Stock Exchange |
£5mn |
|
Laboratorios Farmaceuticos Rovi S.A. |
ROVI |
🇪🇸 |
Madrid Stock Exchange |
€2.8bn |
|
Laboratory Corp. Of America Holdings |
LH |
🇺🇸 |
New York Stock Exchange |
$18.0bn |
S&P 500 |
Lifevantage Corporation |
LFVN |
🇺🇸 |
NASDAQ |
$211mn |
|
Lilly(Eli) & Co |
LLY |
🇺🇸 |
New York Stock Exchange |
$828.9bn |
S&P 100 S&P 500 |
Lonza Group AG |
LONN |
🇨🇠|
SIX Swiss Exchange |
Fr.42.2bn |
STOXX600 |
Mckesson Corporation |
MCK |
🇺🇸 |
New York Stock Exchange |
$75.6bn |
S&P 500 |
Medtronic Plc |
MDT |
🇺🇸 |
New York Stock Exchange |
$112.8bn |
S&P 100 S&P 500 |
Merck & Co Inc |
MRK |
🇺🇸 |
New York Stock Exchange |
$221.8bn |
Dow Jones 30 S&P 100 S&P Global 100 S&P 500 |
Merck KGAA |
MRK |
🇩🇪 |
Frankfurt Stock Exchange |
€17.5bn |
DAX 40 STOXX600 |
MGC Pharmaceuticals Ltd |
MXC |
🇦🇺 |
Australian Stock Exchange |
AU$12mn |
|
Moderna Inc |
MRNA |
🇺🇸 |
NASDAQ |
$13.0bn |
S&P 500 |
Morphosys AG |
MOR |
🇩🇪 |
Frankfurt Stock Exchange |
€2.6bn |
STOXX600 |
Nektar Therapeutics |
NKTR |
🇺🇸 |
NASDAQ |
$177mn |
|
NIOX Group Plc |
NIOX |
🇬🇧 |
London Stock Exchange |
£244mn |
|
Novartis AG - Ordinary Shares (Registered) |
NOVN |
🇨🇠|
SIX Swiss Exchange |
Fr.211.7bn |
FTSE Eurotop 100 S&P Global 100 BBC Global 30 STOXX600 |
Novavax, Inc. |
NVAX |
🇺🇸 |
NASDAQ |
$1.3bn |
|
NovoCure Ltd |
NVCR |
🇺🇸 |
NASDAQ |
$2.3bn |
|
Novonesis AS - Class B Shares |
NSIS B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.166.2bn |
STOXX600 OMX Copenhagen 20 |
Novo Nordisk - ADR |
NVO |
🇺🇸 |
New York Stock Exchange |
$283.9bn |
|
Novo Nordisk - Class B Shares |
NOVO B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.2025.6bn |
OMX Copenhagen 20 STOXX600 |
OptiBiotix Health plc |
OPTI |
🇬🇧 |
London Stock Exchange |
£17mn |
|
Organon & Co. |
OGN |
🇺🇸 |
New York Stock Exchange |
$4.0bn |
S&P 500 |
Oxford BioDynamics Plc |
OBD |
🇬🇧 |
London Stock Exchange |
£11mn |
|
Oxford Biomedica |
OXB |
🇬🇧 |
London Stock Exchange |
£397mn |
FTSE 250 FTSE 350 |
Oxford Nanopore Technologies Plc |
ONT |
🇬🇧 |
London Stock Exchange |
£1.3bn |
|
Patterson Companies Inc. |
PDCO |
🇺🇸 |
NASDAQ |
$2.7bn |
|
Perrigo Company plc |
PRGO |
🇺🇸 |
New York Stock Exchange |
$3.4bn |
|
Pfizer Inc. |
PFE |
🇺🇸 |
New York Stock Exchange |
$146.8bn |
Dow Jones 30 S&P 100 S&P Global 100 S&P 500 |
Pharming Group N.V. |
PHARM |
🇳🇱 |
Euronext Amsterdam |
€594mn |
|
PolarityTE Inc |
PTEIQ |
🇺🇸 |
OTC Markets Group |
$2mn |
|
Provexis Plc |
PXS |
🇬🇧 |
London Stock Exchange |
£14mn |
|
Qiagen NV |
QGEN |
🇺🇸 |
New York Stock Exchange |
$8.8bn |
STOXX600 DAX 40 |
Recordati SpA |
REC |
🇮🇹 |
Italian Stock Exchange |
€11.5bn |
STOXX600 |
Regeneron Pharmaceuticals, Inc. |
REGN |
🇺🇸 |
NASDAQ |
$74.8bn |
S&P 500 |
Roche Holding AG |
ROG |
🇨🇠|
SIX Swiss Exchange |
Fr.207.5bn |
FTSE Eurotop 100 STOXX600 |
Sanofi |
SAN |
🇫🇷 |
Euronext Paris |
€130.2bn |
Euro Stoxx 50 CAC 40 FTSE Eurotop 100 S&P Global 100 Euronext 100 TSIC Euro30 STOXX600 |
Sareum Holdings Plc |
SAR |
🇬🇧 |
London Stock Exchange |
£22mn |
|
Sartorius AG |
SRT |
🇩🇪 |
Frankfurt Stock Exchange |
€7.1bn |
|
Sartorius AG - Preference Share |
SRT3 |
🇩🇪 |
Frankfurt Stock Exchange |
€9.0bn |
STOXX600 DAX 40 |
Sartorius Stedim Biotech S.A. |
DIM |
🇫🇷 |
Euronext Paris |
€19.8bn |
STOXX600 |
Siemens Healthineers AG |
SHL |
🇩🇪 |
Frankfurt Stock Exchange |
€62.6bn |
STOXX600 DAX 40 |
Sonova Holding AG |
SOON |
🇨🇠|
SIX Swiss Exchange |
Fr.17.3bn |
STOXX600 |
Steris Plc |
STE |
🇺🇸 |
New York Stock Exchange |
$21.7bn |
S&P 500 |
Sundial Growers Inc |
SNDL |
🇺🇸 |
NASDAQ |
$414mn |
|
Swedencare AB |
SECARE |
🇸🇪 |
Stockholm Stock Exchange |
kr7.2bn |
|
Swedish Orphan Biovitrum AB |
SOBI |
🇸🇪 |
Stockholm Stock Exchange |
kr111.9bn |
STOXX600 |
Synairgen |
SNG |
🇬🇧 |
London Stock Exchange |
£4mn |
|
Syncona Limited |
SYNC |
🇬🇧 |
London Stock Exchange |
£592mn |
FTSE 250 FTSE 350 |
Takeda Pharmaceutical Co |
4502 |
🇯🇵 |
Tokyo Stock Exchange |
Â¥6619.9bn |
|
Takeda Pharmaceutical Co - ADR |
TAK |
🇺🇸 |
New York Stock Exchange |
$44.1bn |
|
Teleflex Incorporated |
TFX |
🇺🇸 |
New York Stock Exchange |
$8.1bn |
S&P 500 |
Teva- Pharmaceutical Industries Ltd. - ADR |
TEVA |
🇺🇸 |
New York Stock Exchange |
$19.3bn |
|
Tilray Brands Inc |
TLRY |
🇺🇸 |
NASDAQ |
$814mn |
|
Tissue Regenix Group Plc |
TRX |
🇬🇧 |
London Stock Exchange |
£31mn |
|
UCB SA |
UCB |
🇧🇪 |
Euronext Brussels |
€35.0bn |
BEL 20 Euronext 100 STOXX600 |
Uniphar Plc |
UPR |
🇮🇪 |
Irish Stock Exchange |
€662mn |
|
Venture Life Group Plc |
VLG |
🇬🇧 |
London Stock Exchange |
£51mn |
|
Vertex Pharmaceuticals, Inc. |
VRTX |
🇺🇸 |
NASDAQ |
$123.3bn |
NASDAQ 100 S&P 500 |
Viatris Inc |
VTRS |
🇺🇸 |
NASDAQ |
$13.2bn |
S&P 500 |
West Pharmaceutical Services, Inc. |
WST |
🇺🇸 |
New York Stock Exchange |
$14.7bn |
S&P 500 |
Zealand Pharma A/S. |
ZEAL |
🇩🇰 |
Copenhagen Stock Exchange |
kr.54.8bn |
|